IBB vs IXJ: holdings overlap, shared companies and scores
As of October 28, 2026, IBB and IXJ overlap 10.4% by weight. iShares Biotechnology ETF (IBB): U.S. biotechnology stocks. iShares Global Healthcare ETF (IXJ): Global healthcare sector stocks.
Updated October 28, 2026
Where IBB and IXJ trade against their own history
IBB trades at 28.9 times earnings, against its own median of 21.6, and is more expensive than 88% of its own last 7 years.
IXJ trades at 29.7 times earnings, against its own median of 24.8, and is more expensive than 93% of its own last 9 years.
What moved IBB and IXJ this week
IBB rose 2.3% in the week to October 28, 2026. The holdings that moved it most were Genmab A/S (+44.8%), Gilead Sciences (+3.7%) and Amgen (+3.1%); Moderna (−12.9%) pushed the other way.
IXJ rose 0.5% in the week to October 28, 2026. The holdings that moved it most were Johnson & Johnson (+5.1%), Genmab A/S (+46.4%) and Eli Lilly (+1.4%); Merck (−6.0%) pushed the other way.
What do IBB and IXJ each hold?
What's inside IBB: AI 1%.
51% of IBB is its ten largest holdings.
What's inside IXJ: AI 0%.
48% of IXJ is its ten largest holdings.
How much do IBB and IXJ overlap? 10.4% by weight
As of October 28, 2026, IBB and IXJ overlap 10.4% by weight.
46% of IBB is already inside IXJ.
10% of IXJ is already inside IBB.
IBB holds 240 companies and IXJ holds 123; 12 are in both.
Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.
How does ETF Copilot score IBB and IXJ? 4.3 and 5.1 out of 10
As of October 28, 2026, ETF Copilot scores IBB 4.3 out of 10 and IXJ 5.1 out of 10.
They differ most on Quality: IBB 0.9 and IXJ 7.2.
The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.
| Factor | IBB | IXJ |
|---|---|---|
| Growth | 9.5 | 5.2 |
| Value | 0.2 | 1.9 |
| Risk | 2.8 | 8.1 |
| Quality | 0.9 | 7.2 |
| Return | 5.0 | 3.8 |
IXJ is the cheaper of the two at 0.38% a year
As of October 28, 2026, IBB charges 0.44% a year, yields 0.14% and holds $11.0B in assets across 240 positions.
As of October 28, 2026, IXJ charges 0.38% a year, yields 1.33% and holds $4.5B in assets across 123 positions.
| Measure | IBB | IXJ |
|---|---|---|
| Expense ratio | 0.44% | 0.38% |
| Dividend yield | 0.14% | 1.33% |
| Assets under management | $11.0B | $4.5B |
| Holdings | 240 | 123 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Compare with similar funds
Cite this
ETF Copilot, “IBB vs IXJ holdings overlap and scores”, as of October 28, 2026.
https://etf-copilot.com/compare/ibb-vs-ixj
ETF Copilot Pro unlocks IBB vs IXJ prices and holdings.
Try Pro free →